EPS Bio Technology Corp.

NT$14.40As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4183Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (1.21%)
Div yield 4.65%
ROE (9.09%)
Medical Devices
Beta (5Y) (0.03)
PE TTM —
TSR TTM (20.88%)
Mkt cap NT$342.7M
ROIC (12.11%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$16
11.41%
(86.12%)
Hold 4|1|1|1|9
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.38
0.37
0.40
0.42
26.79%
16.10%
24.71%
22.54%
RevenueNT$M
26.03
26.04
27.59
28.34
7.65%
9.66%
16.05%
14.39%
Peers (US$10.35M)
Cap (US$)
PE
9.967M
—
9.080M
—
Capital
TTM
5Y
10Y
Leveragex
1.082
0.076
0.075
EBIT/Intx
1.180
0.858
0.755
Own earn%
(30.69)
(107.91)
(90.88)
Sh yield%
34.75
20.77
24.98
Owners
Insiders/Inst%
8.98
48.37
Short interest%
1.08
SBC / revenue%
4.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
1–14
$1 testx
—
Incr. ROIC%
12